Tg Therapeutics, Inc. · NASDAQ:TGTX
BlackRock, Inc. reported a 12.80% stake in Tg Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
BlackRock, Inc. reported a 12.80% stake in Tg Therapeutics, Inc., 20,134,882 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 12.80%
- Shares
- 20,134,882
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 12.80% | 20,134,882 |
Source
Related
- Tg Therapeutics, Inc.
- BlackRock, Inc.
- Tg Therapeutics, Inc. shareholders
- Form 4 · Charney Laurence N · Sep 14, 2026
- Form 4 · Charney Laurence N · Aug 7, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Apr 29, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · State Street Corp · Nov 10, 2025